The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

J Allergy Clin Immunol Pract. 2021 May;9(5):2093-2096.e1. doi: 10.1016/j.jaip.2021.01.008. Epub 2021 Jan 21.
No abstract available

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Humans

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • benralizumab
  • mepolizumab